These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7996901)

  • 1. [The use of lovastatin in patients with hyperlipemia following heart transplantation treated with cyclosporine].
    Anguita M; Alonso-Pulpón L; Arizón JM; Vallés F
    Med Clin (Barc); 1994 Oct; 103(12):477-8. PubMed ID: 7996901
    [No Abstract]   [Full Text] [Related]  

  • 2. [A comparison of bezafibrate and lovastatin treatment at the usual doses in post-heart transplant hyperlipemia].
    Zambrana García JL; López Miranda J; Anguita Sánchez M; Blanco Cerrada J; Vallés Belsúe F; Casares Mediavilla J; Muñoz Carvajal I; Jiménez Perepérez JA; Pérez Jiménez F
    Rev Esp Cardiol; 1996 Dec; 49(12):892-8. PubMed ID: 9026840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of hyperlipidemia with lovastatin in kidney transplant patients on cyclosporine A immunosuppression: three-year experience.
    Kandus A; Kovac D; Cerne D; Koselj M; Kaplan-Pavlovcic S; Buturović J; Ponikvar R; Kveder R; Lindic J; Bren AF
    Transplant Proc; 1998 Jun; 30(4):1307-9. PubMed ID: 9636530
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of hyperlipidemia after heart transplantation and rationale for the Heart Transplant Lipid Registry.
    Ballantyne CM; Bourge RC; Domalik LJ; Eisen HJ; Fishbein DP; Kubo SH; Lake KD; Radovancevic B; Taylor DO; Ventura HO; Yancy CW; Young JB
    Am J Cardiol; 1996 Sep; 78(5):532-5. PubMed ID: 8806337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bezafibrate and lovastatin decrease the oxidizability of low-density lipoproteins in heart transplant recipients with hyperlidemia.
    Zambrana JL; López-Miranda J; Blanco A; Arizón JM; Jansen S; Paniagua JA; Jimenéz-Perepérez JA; Concha M; Pérez-Jiménez F
    J Heart Lung Transplant; 1998 Dec; 17(12):1213-9. PubMed ID: 9883763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of hydroxymethylglutaryl coenzyme A reductase inhibitors in patients with post-transplantation hyperlipemia].
    Martínez-Castelao A
    Med Clin (Barc); 1995 Nov; 105(18):719. PubMed ID: 8538262
    [No Abstract]   [Full Text] [Related]  

  • 7. Rhabdomyolysis in patients receiving lovastatin after cardiac transplantation.
    East C; Alivizatos PA; Grundy SM; Jones PH; Farmer JA
    N Engl J Med; 1988 Jan; 318(1):47-8. PubMed ID: 3275892
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of hyperlipidemia in heart transplant recipients with gemfibrozil +/- lovastatin.
    Peters JR; Kubo SH; Olivari MT; Knutson KR; Hunninghake DB
    Am J Cardiol; 1993 Jun; 71(16):1485-8. PubMed ID: 8517408
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipid-lowering effects of lovastatin in CAPD patients.
    Jacobs RH; Lal SM; Nolph KD
    Adv Perit Dial; 1993; 9():288-90. PubMed ID: 8105945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of simvastatin in hyperlipidemic renal transplant patients receiving cyclosporine.
    Rehman MA; al-Sulaiman MH; Mousa DH; al-Hawas FA; Abdalla AH; Rassoul Z; al-Khader AA
    Transplantation; 1995 Aug; 60(4):397-9. PubMed ID: 7652773
    [No Abstract]   [Full Text] [Related]  

  • 11. Rhabdomyolysis and acute renal failure in a heart transplant recipient treated with hypolipemiants.
    de Alava E; Sola JJ; Lozano MD; Pardo-Mindán FJ
    Nephron; 1994; 66(2):242-3. PubMed ID: 8139752
    [No Abstract]   [Full Text] [Related]  

  • 12. Supratherapeutic response to ezetimibe administered with cyclosporine.
    Koshman SL; Lalonde LD; Burton I; Tymchak WJ; Pearson GJ
    Ann Pharmacother; 2005 Sep; 39(9):1561-5. PubMed ID: 16030077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative effectiveness of niacin and lovastatin for treatment of dyslipidemias in a health maintenance organization.
    O'Connor PJ; Rush WA; Trence DL
    J Fam Pract; 1997 May; 44(5):462-7. PubMed ID: 9152263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of lovastatin, but not pravastatin, in the blood of cyclosporine-treated kidney graft patients after multiple doses.
    Olbricht C; Wanner C; Eisenhauer T; Kliem V; Doll R; Boddaert M; O'Grady P; Krekler M; Mangold B; Christians U
    Clin Pharmacol Ther; 1997 Sep; 62(3):311-21. PubMed ID: 9333107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rhabdomyolysis in a patient treated with lovastatin and cyclosporine].
    Hermida Lazcano I; Revillo Pinilla P; Nerin Sánchez C; Lechuga Durán I; Fernández López J
    An Med Interna; 1997 Sep; 14(9):488. PubMed ID: 9453765
    [No Abstract]   [Full Text] [Related]  

  • 16. Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: the Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion.
    White M; Haddad H; Leblanc MH; Giannetti N; Pflugfelder P; Davies R; Isaac D; Burton J; Chan M; Azevedo E; Howlett J; Ignaszewski A; Busque S; Cantarovich M; Ferguson R; Genest J; Ross H
    J Heart Lung Transplant; 2005 Jul; 24(7):798-809. PubMed ID: 15982605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lovastatin.
    Feeman WE
    Am Fam Physician; 1988 Aug; 38(2):65-7. PubMed ID: 3407588
    [No Abstract]   [Full Text] [Related]  

  • 18. Rhabdomyolysis and renal failure secondary to combination therapy of hyperlipidemia with lovastatin and gemfibozil.
    Knoll RW; Ciafone R; Galen M
    Conn Med; 1993 Sep; 57(9):593-4. PubMed ID: 8252847
    [No Abstract]   [Full Text] [Related]  

  • 19. HMGCoA reductase inhibitors lovastatin and simvastatin in the treatment of hypercholesterolemia after renal transplantation.
    Castelao AM; Griñó JM; Andrés E; Gilvernet S; Serón D; Castiñeiras MJ; Roca M; Galcerán JM; González MT; Alsina J
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1043-6. PubMed ID: 8442035
    [No Abstract]   [Full Text] [Related]  

  • 20. Rhabdomyolysis triggered by cytomegalovirus infection in a heart transplant patient on concomitant cyclosporine and atorvastatin therapy.
    Wong WM; Wai-Hung Shek T; Chan KH; Chau E; Lai KC
    J Gastroenterol Hepatol; 2004 Aug; 19(8):952-3. PubMed ID: 15242511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.